Sedana Medical AB (publ)
STO:SEDANA
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Sedana Medical AB (publ)
Income from Continuing Operations
Sedana Medical AB (publ)
Income from Continuing Operations Peer Comparison
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Sedana Medical AB (publ)
STO:SEDANA
|
Income from Continuing Operations
-kr22.8m
|
CAGR 3-Years
15%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
Elekta AB (publ)
STO:EKTA B
|
Income from Continuing Operations
kr1.3B
|
CAGR 3-Years
1%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
CellaVision AB
STO:CEVI
|
Income from Continuing Operations
kr141.2m
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
18%
|
|
Getinge AB
STO:GETI B
|
Income from Continuing Operations
kr2.4B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Arjo AB (publ)
STO:ARJO B
|
Income from Continuing Operations
kr480m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
Elos Medtech AB
STO:ELOS B
|
Income from Continuing Operations
kr75.1m
|
CAGR 3-Years
25%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
See Also
What is Sedana Medical AB (publ)'s Income from Continuing Operations?
Income from Continuing Operations
-22.8m
SEK
Based on the financial report for Mar 31, 2024, Sedana Medical AB (publ)'s Income from Continuing Operations amounts to -22.8m SEK.
What is Sedana Medical AB (publ)'s Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
-19%
Over the last year, the Income from Continuing Operations growth was 68%. The average annual Income from Continuing Operations growth rates for Sedana Medical AB (publ) have been 15% over the past three years , -19% over the past five years .